Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1996 Jul;70(7):4246–4252. doi: 10.1128/jvi.70.7.4246-4252.1996

Characterization of inhibition of M2 ion channel activity by BL-1743, an inhibitor of influenza A virus.

Q Tu 1, L H Pinto 1, G Luo 1, M A Shaughnessy 1, D Mullaney 1, S Kurtz 1, M Krystal 1, R A Lamb 1
PMCID: PMC190355  PMID: 8676445

Abstract

The influenza A virus M2 integral membrane protein has ion channel activity that can be inhibited by the antiviral drug amantadine. Recently, a spirene-containing compound, BL-1743 (2-[3-azaspiro (5,5)undecanol]-2-imidazoline), that inhibits influenza virus growth was identified (S. Kurtz, G. Lao, K. M. Hahnenberger, C. Brooks, O. Gecha, K. Ingalls, K.-I. Numata, and M. Krystal, Antimicrob. Agents Chemother. 39:2204-2209, 1995). We have examined the ability of BL-1743 to inhibit the M2 ion channel when expressed in oocytes of Xenopus laevis. BL-1743 inhibition is complete as far as can be measured by electrophysiological methods and is reversible, with a reverse reaction rate constant of 4.0 x 10(-3) s(-1). In contrast, amantadine inhibition is irreversible within the time frame of the experiment. However, BL-1743 inhibition and amantadine inhibition have similar properties. The majority of isolated influenza viruses resistant to BL-1743 are also amantadine resistant. In addition, all known amino acid changes which result in amantadine resistance also confer BL-1743 resistance. However, one BL-1743-resistant virus isolated, designated M2-I35T, contained the change Ile-35-->Thr. This virus is >70-fold more resistant to BL-1743 and only 10-fold more resistant to amantadine than the wild-type virus. When the ion channel activity of M2-I35T was examined in oocytes, it was found that M2-I35T is BL-1743 resistant but is reversibly inhibited by amantadine. These findings suggest that these two drugs interact differently with the M2 protein transmembrane pore region.

Full Text

The Full Text of this article is available as a PDF (353.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black R. A., Rota P. A., Gorodkova N., Cramer A., Klenk H. D., Kendal A. P. Production of the M2 protein of influenza A virus in insect cells is enhanced in the presence of amantadine. J Gen Virol. 1993 Aug;74(Pt 8):1673–1677. doi: 10.1099/0022-1317-74-8-1673. [DOI] [PubMed] [Google Scholar]
  2. Duff K. C., Ashley R. H. The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers. Virology. 1992 Sep;190(1):485–489. doi: 10.1016/0042-6822(92)91239-q. [DOI] [PubMed] [Google Scholar]
  3. Duff K. C., Gilchrist P. J., Saxena A. M., Bradshaw J. P. Neutron diffraction reveals the site of amantadine blockade in the influenza A M2 ion channel. Virology. 1994 Jul;202(1):287–293. doi: 10.1006/viro.1994.1345. [DOI] [PubMed] [Google Scholar]
  4. Giffin K., Rader R. K., Marino M. H., Forgey R. W. Novel assay for the influenza virus M2 channel activity. FEBS Lett. 1995 Jan 9;357(3):269–274. doi: 10.1016/0014-5793(94)01369-c. [DOI] [PubMed] [Google Scholar]
  5. Guinea R., Carrasco L. Influenza virus M2 protein modifies membrane permeability in E. coli cells. FEBS Lett. 1994 May 2;343(3):242–246. doi: 10.1016/0014-5793(94)80564-4. [DOI] [PubMed] [Google Scholar]
  6. Hay A. J., Wolstenholme A. J., Skehel J. J., Smith M. H. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 1985 Nov;4(11):3021–3024. doi: 10.1002/j.1460-2075.1985.tb04038.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Holsinger L. J., Lamb R. A. Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology. 1991 Jul;183(1):32–43. doi: 10.1016/0042-6822(91)90115-r. [DOI] [PubMed] [Google Scholar]
  8. Holsinger L. J., Shaughnessy M. A., Micko A., Pinto L. H., Lamb R. A. Analysis of the posttranslational modifications of the influenza virus M2 protein. J Virol. 1995 Feb;69(2):1219–1225. doi: 10.1128/jvi.69.2.1219-1225.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hull J. D., Gilmore R., Lamb R. A. Integration of a small integral membrane protein, M2, of influenza virus into the endoplasmic reticulum: analysis of the internal signal-anchor domain of a protein with an ectoplasmic NH2 terminus. J Cell Biol. 1988 May;106(5):1489–1498. doi: 10.1083/jcb.106.5.1489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kurtz S., Luo G., Hahnenberger K. M., Brooks C., Gecha O., Ingalls K., Numata K., Krystal M. Growth impairment resulting from expression of influenza virus M2 protein in Saccharomyces cerevisiae: identification of a novel inhibitor of influenza virus. Antimicrob Agents Chemother. 1995 Oct;39(10):2204–2209. doi: 10.1128/aac.39.10.2204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lamb R. A., Zebedee S. L., Richardson C. D. Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell. 1985 Mar;40(3):627–633. doi: 10.1016/0092-8674(85)90211-9. [DOI] [PubMed] [Google Scholar]
  12. Ohuchi M., Cramer A., Vey M., Ohuchi R., Garten W., Klenk H. D. Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein. J Virol. 1994 Feb;68(2):920–926. doi: 10.1128/jvi.68.2.920-926.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Paterson R. G., Lamb R. A. RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. J Virol. 1990 Sep;64(9):4137–4145. doi: 10.1128/jvi.64.9.4137-4145.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ritchey M. B., Palese P., Kilbourne E. D. RNAs of influenza A, B, and C viruses. J Virol. 1976 May;18(2):738–744. doi: 10.1128/jvi.18.2.738-744.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Schroeder C., Ford C. M., Wharton S. A., Hay A. J. Functional reconstitution in lipid vesicles of influenza virus M2 protein expressed by baculovirus: evidence for proton transfer activity. J Gen Virol. 1994 Dec;75(Pt 12):3477–3484. doi: 10.1099/0022-1317-75-12-3477. [DOI] [PubMed] [Google Scholar]
  17. Shimbo K., Brassard D. L., Lamb R. A., Pinto L. H. Ion selectivity and activation of the M2 ion channel of influenza virus. Biophys J. 1996 Mar;70(3):1335–1346. doi: 10.1016/S0006-3495(96)79690-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sugrue R. J., Bahadur G., Zambon M. C., Hall-Smith M., Douglas A. R., Hay A. J. Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO J. 1990 Nov;9(11):3469–3476. doi: 10.1002/j.1460-2075.1990.tb07555.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sugrue R. J., Hay A. J. Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology. 1991 Feb;180(2):617–624. doi: 10.1016/0042-6822(91)90075-M. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Takeuchi K., Lamb R. A. Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport. J Virol. 1994 Feb;68(2):911–919. doi: 10.1128/jvi.68.2.911-919.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tosteson M. T., Pinto L. H., Holsinger L. J., Lamb R. A. Reconstitution of the influenza virus M2 ion channel in lipid bilayers. J Membr Biol. 1994 Oct;142(1):117–126. doi: 10.1007/BF00233389. [DOI] [PubMed] [Google Scholar]
  22. Wang C., Lamb R. A., Pinto L. H. Activation of the M2 ion channel of influenza virus: a role for the transmembrane domain histidine residue. Biophys J. 1995 Oct;69(4):1363–1371. doi: 10.1016/S0006-3495(95)80003-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wang C., Lamb R. A., Pinto L. H. Direct measurement of the influenza A virus M2 protein ion channel activity in mammalian cells. Virology. 1994 Nov 15;205(1):133–140. doi: 10.1006/viro.1994.1628. [DOI] [PubMed] [Google Scholar]
  24. Wang C., Takeuchi K., Pinto L. H., Lamb R. A. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J Virol. 1993 Sep;67(9):5585–5594. doi: 10.1128/jvi.67.9.5585-5594.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Zebedee S. L., Lamb R. A. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol. 1988 Aug;62(8):2762–2772. doi: 10.1128/jvi.62.8.2762-2772.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Zebedee S. L., Richardson C. D., Lamb R. A. Characterization of the influenza virus M2 integral membrane protein and expression at the infected-cell surface from cloned cDNA. J Virol. 1985 Nov;56(2):502–511. doi: 10.1128/jvi.56.2.502-511.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES